PPT-Session 7 Decentralized Drug Distribution of Antiretroviral Therapy in the Private Sector:

Recording and Reporting Service Delivery Data Learning objectives By the end of this session participants will be able to Describe the information that needs to be collected and reported Explain how and when to report the data. C:. What . is the business value for private sector partners. ?. Session Facilitator:. Mr. . Scott . Winn. CEO. Strajillion. 1. 1. Network Management Interoperability Technical Exchange. 2. Breakout Session C: What is the business value for private sector partners?. Steffen Hertog. London School of Economics. The GCC private sector at first glance. Employs 80% of workers in the region. Provides the majority of local capital formation. Has deep overseas capital resources. 1. Colombo, Sri Lanka. March 17-19, 2015. Expanding Private Sector Engagement. Private sector engagement is not new; but GEF projects can deliver more by partnering on sustainable business models and attracting more investment for environmental . P. . Banerjee, . S. . Niddodi. , . H. . Lee, . A. . Srivastava. . and D. . Bakken. The School of Electrical Engineering and Computer Science. Washington State University. Patrick . Panciatici. RTE France. Camille Angle, Meagan Bardan, Hanna Schimjawicz and Sean Tabarah. PHM142 Fall . 2018. Instructor: . Ms. Maya Latif. Coordinator: Dr. J. Henderson. HIV Attachment and Penetration. Wilen, C. B., Tilton, J. C., & Doms, R. W. D. (2012). HIV: Cell binding and entry. . Sean Schafer MD. May 31, 2012. Three Studies in One. Evaluating antiretroviral drug resistance surveillance in Oregon. Determining frequency of transmitted antiretroviral drug resistance, comparing to U.S.. A CSO perspective. By Jiten Yumnam. Focal Point Person, Rural Sector, Asia, . CSO partnership for Development Effectiveness . mangangmacha@gmail.com. . Increasing Emphasis on private sector and partners of development . ACTIVITY CODE . TD342. Antiretroviral Medications: . What . you need to know. Jason J. Schafer, PharmD, MPH, BCPS, AAHIVP. Associate Professor, Department of Pharmacy Practice. Antiretroviral Pregnancy Registry. LM Mofenson, V . Vannappagari. , AE . Scheuerle. , B Baugh,. KP Beckerman, H . Betman. , N . Chakhtoura. , K Dominguez, A . Pikis. , NS . Santanello. . Trikudanathan. , MD, MRCP, . MMSc. Division of Endocrinology, Metabolism and Nutrition. University of Washington Medical Center. Presentation prepared by: . S. . Trikudanathan. Presenter: S. . Trikudanathan. Learning objectives. By the end of this session, participants will be able to:. Discuss how to create demand for private sector DDD of ART . Identify clients who qualify for DDD enrollment. Describe the process for enrolling clients into DDD of ART. A5173 Study. Intensive . Enfuvirtide. -containing Antiretroviral Therapy . A5173: . Study Design. Source: Gandhi RT, et al. . J . Infect. . Dis. . . 2010;201(2. ):293-6.. Enfuvirtide. +. TDF + (FTC or 3TC) +. Learning objectives. By the end of this session, participants will be able to:. Explain the rationale for decentralized drug distribution (DDD) of antiretroviral therapy (ART). List the various DDD of ART models. Constance A. Benson, MD. Professor of Medicine and Global Public Health. University of California San Diego. La Jolla, California. Goals for the Workshop. To describe the potential benefits of long-acting antiretroviral drugs (ARVs) for treatment and prevention of HIV infection.